New York Consolidated Laws, General Business Law - GBS § 398-g. Kratom package labeling

(i) that sale or distribution by individuals who are under twenty-one years of age is prohibited under the public health law;

(ii) that use by individuals who are pregnant or breastfeeding is not advised;

(iii) to consult a healthcare professional prior to use;

(iv) that kratom may be addictive;

(v) that kratom may interact with certain medications, drugs, and controlled substances;

(vi) whether the product includes a semisynthesized chemical or compound or synthesized chemical or compound of kratom.  For the purposes of this subparagraph the term “semisynthesized chemical or compound” shall mean a chemical or compound contained in a kratom extract that has been exposed to chemicals or processes that would confer a structural change in the chemical or compound, such as oxidation, reduction, and ring opening and closing, resulting in material that has been chemically altered.  For the purposes of this subparagraph the term “synthesized chemical or compound” shall mean a chemical or compound of kratom that has been created by chemical synthesis or biosynthetic means, including fermentation, recombinant techniques, and enzymatic techniques, rather than by traditional food preparation techniques such as heating or extracting;  and

(vii) quantitative declarations of the amount of mitragynine and the amount of 7hydroxymitragynine by part, weight or volume of the kratom product;  and

(i) “These statements have not been evaluated by the food and drug administration.  This product is not intended to diagnose, treat, cure, or prevent any disease.”;  and

(ii) “Keep out of reach of children.”